Management Team
 

Dr. Aharon Schwartz


Aharon serves as Vice President Innovative Ventures for Teva Pharmaceutical Industries Ltd. He has served as Vice President - Strategic Business Planning and New and as Vice President - Global Products Division. In addition, Aharon was Vice President of the Copaxone Division, Vice President Business Development/Export Division and Head of the Pharmaceutical Division – all at Teva Pharmaceutical Industries Ltd.

Aharon is Chairman of BioLineRx, and also serves as a director with D-Pharm, MediWound, CureTech, and Van Leer Ventures, Jerusalem

Aharon received his Ph.D. in chemistry from the Weizmann Institute.


 

Ruben Krupik, CEO
 

Ofer Goldberg, Vice President
 

Ofer Gonen, Vice President
 

Amos Bankirer, Vice President
 

Orit Lidor, VP & General Counsel
 

Gil Milner, CFO
  Board Members

 

Avi Fischer
 

Dr. Aharon Schwartz
 

Prof. Gabi Barabash
 

Dr. Tamar Manor
 

Shmuel (Milki) Rubinstein
 

Avi Zigelman
 

Yoni Kaplan
 
 
  Home | Profile | Team | Portfolio | Contact Us All Rights Reserved to Clal Biotechnology Industries Ltd.